PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,088.00
Bid: 12,086.00
Ask: 12,088.00
Change: -22.00 (-0.18%)
Spread: 2.00 (0.017%)
Open: 12,090.00
High: 12,116.00
Low: 12,060.00
Prev. Close: 12,110.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Muted Friday Unable To Dent Positive Week

Fri, 27th Nov 2020 17:03

(Alliance News) - Stocks in London limped to a lacklustre end to the week on Friday, with AstraZeneca's potential coronavirus vaccine coming under increased scrutiny.

The UK government said it has asked its independent medicines regulator to assess AstraZeneca's vaccine as part of the formal approval process for the drug to be rolled out by the end of the year.

AstraZeneca has completed phase 3 clinical trials of its vaccine, the last stage before regulatory approval. But under British rules, the government must also ask the independent Medicines & Healthcare products Regulatory Agency to green light the drug.

Astra added 0.4% Friday.

On Thursday, the head of British drug manufacturer AstraZeneca said further research was needed on its Covid-19 vaccine after questions emerged over the protection it could offer.

"Now that we've found what looks like a better efficacy we have to validate this, so we need to do an additional study," Chief Executive Pascal Soriot told Bloomberg in an interview.

The FTSE 100 index added 4.65 points, or 0.1%, at 6,367.58. The large-cap index added 0.6 % this week.

The mid-cap FTSE 250 index gained 66.37 points, or 0.3%, at 19,462.71. The AIM All-Share index ended slightly higher, gaining 0.98 of a point, at 1,039.01.

The Cboe UK 100 index closed 0.1% higher at 634.21. The Cboe 250 closed down 1.0% at 16,581.96. The Cboe Small Companies ended down 1.5% at 11,276.56.

"As the final full week of November trading winds down we find markets still in a guardedly-positive mood. It has been a great month, continuing of course the strong run since March for many markets, and while it might not be going out on a high there is still no sign of any correction on the horizon," IG's Chief Market Analyst Chris Beauchamp said.

He continued: "However, high sentiment and breadth readings should give investors pause, with a legitimate question being how much of the expected December gain has been pulled forward into the preceding month. While election concerns seem to have almost entirely disappeared, and rightly so given Trump's comments about making way for the new administration, the virus situation remains, and still has the power to shock should the Thanksgiving holiday produce another surge in US cases."

UK stocks were underperforming those in in mainland Europe. The CAC 40 in Paris and the DAX 30 in Frankfurt advanced 0.6% and 0.4%, respectively.

"The difference between the FTSE and its Western peers is the underlying Brexit talk anxieties that are only going to become more pronounced in the coming days and weeks - and sent the pound 0.3% lower against the euro - and fears that the Oxford/AstraZeneca vaccine might not be quite as effective as first claimed," SpreadEx analyst Connor Campbell.

A Brexit deal is still possible, the UK's chief negotiator has insisted as face-to-face negotiations are set to resume with the clock ticking down to an agreement deadline.

But David Frost warned that a deal is only possible if Brussels recognised British sovereignty in key areas.

Frost was speaking ahead of face-to-face talks, which he said would take place on Saturday.

The comments came after EU chief negotiator Michel Barnier warned that "significant divergences" still remain ahead of the UK exiting the Brexit transition period at the end of December.

The pound was quoted at USD1.3331 on Friday evening, broadly flat from USD1.3333 at the London equities close Thursday.

The euro stood at USD1.1957, up from USD1.1908. Against the Japanese yen, the dollar was trading at JPY103.99, down from JPY104.27.

Wall Street was painted green on Friday's half-day, with the Dow Jones Industrial Average up 0.1%, the S&P 500 up 0.3% and the Nasdaq Composite up 1.1%.

Financial markets in the US reopened for a half-day on Friday after being closed on Thursday for Thanksgiving.

In London, Homserve gave back 1.3%. The home emergency cover provider finds itself on the brink of automatic demotion from the large-cap index ahead of the FTSE Russell index review changes next week. Homeserve currently ranks 115th in the FTSE 350 by market capitalisation, just below the safety threshold at 110th place, with a total market value of GBP3.4 billion.

In the FTSE 250, Indivior was the worst performer, closing down 20% after the drugmaker said Reckitt Benckiser has submitted a GBP1.07 billion claim against the company.

The claim related to an indemnity contained in the demerger agreement entered into between the two companies in November 2014. Indivior spun off from consumer health and hygiene firm Reckitt and listed on the London Stock Exchange in December of that year.

The claim was submitted on November 13.

Indivior said: "The claim has not been served on the company and the company does not have any further details at this time. The company will assess with its advisors the background and merits to the case and will provide an update in due course."

Reckitt lost 1.3% Friday.

JD Wetherspoon bounced back in afternoon trade, gaining 1.2%, despite opening down 4.9%. The pub chain complained bitterly about the UK government's post-lockdown tier system, which effectively forces almost half of its about 870 pubs to close.

Just 13 Wetherspoon pubs in England are in areas classified as Tier 1, under the new UK virus restrictions that go into place from next week. In addition, there are 51 pubs in Wales, where the regulations equate to Tier 1 in England.

In Tier 1, the rule of six applies indoors and outdoors, but in Tier 2 there will be a ban on households mixing indoors, and pubs and restaurants will only be able to sell alcohol with a "substantial meal". Tier 3 measures mean a ban on households mixing, except in limited circumstances such as in parks.

For Wetherspoon, Tier 2 affects 435 pubs. This tier includes 17 pubs in Scotland where the regulations approximate to Tier 2 in England, the pub chain said.

"These rules greatly reduced pub capacity and provided strict social distancing and hygiene standards but, with difficultly, allowed pubs to trade viably. It is very disappointing that yet another raft of regulations has been introduced, which has effectively closed half our pubs," said Chair Tim Martin.

Brent oil was trading at USD48.05 a barrel Friday evening, up from USD47.77 late Thursday. Gold fetched USD1,786.40 an ounce, lower from USD1,810.32.

A busy global economic calendar next week is headlined by US Fed Chair Jerome Powell testifying before Congress on Tuesday and US non-farm payrolls and unemployment on Friday.

On Monday, there is China non-manufacturing PMI overnight and German consumer price index at 1300 GMT. There is a slew of manufacturing manufacturing PMIs, with Japan and China overnight, followed by Germany, eurozone, and UK at 0855 GMT, 0900 GMT and 0930 GMT, respectively. US Markit manufacturing is due 1445 GMT.

On Thursday, there will be a run of service PMI readings, with China and Japan overnight, then Germany, eurozone and UK at 0855 GMT, 0900 GMT and 0930 GMT, respectively. US ISM services at 1500 GMT.

The local corporate calendar on Monday has half-year results from electronic parts supplier discoverIE Group, carpet designer Victoria, venture capital firm Draper Esprit, and social housing investor Civitas Social Housing.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.